Search Results

There are 2196354 results for: content related to: Genetic resistance to warfarin therapy masked by amiodarone in a 2-year-old girl with mitral valve replacement

  1. You have free access to this content
    A new cell culture-based assay quantifies vitamin K 2,3-epoxide reductase complex subunit 1 function and reveals warfarin resistance phenotypes not shown by the dithiothreitol-driven VKOR assay

    Journal of Thrombosis and Haemostasis

    Volume 11, Issue 5, May 2013, Pages: 872–880, A. Fregin, K. J. Czogalla, J. Gansler, S. Rost, M. Taverna, M. Watzka, C. G. Bevans, C. R. MüLler and J. Oldenburg

    Version of Record online : 15 MAY 2013, DOI: 10.1111/jth.12185

  2. Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans

    Journal of Thrombosis and Haemostasis

    Volume 15, Issue 4, April 2017, Pages: 735–743, W. Hernandez, E. R. Gamazon, K. Aquino-Michaels, E. Smithberger, T. J. O'Brien, A. F. Harralson, M. Tuck, A. Barbour, L. H. Cavallari and M. A. Perera

    Version of Record online : 25 MAR 2017, DOI: 10.1111/jth.13639

  3. Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists

    Journal of Thrombosis and Haemostasis

    Volume 15, Issue 11, November 2017, Pages: 2165–2175, M. Nagler, A. Angelillo-Scherrer, M. Méan, A. Limacher, C. Abbal, M. Righini, J. H. Beer, J. Osterwalder, B. Frauchiger, M. Aschwanden, C. M. Matter, N. Kucher, J. Cornuz, M. Banyai, M. Husmann, D. Staub, L. Mazzolai, O. Hugli, N. Rodondi and D. Aujesky

    Version of Record online : 25 SEP 2017, DOI: 10.1111/jth.13810

  4. Dosing algorithms for vitamin K antagonists across VKORC1 and CYP2C9 genotypes

    Journal of Thrombosis and Haemostasis

    Volume 15, Issue 3, March 2017, Pages: 465–472, E. V. Baranova, T. I. Verhoef, G. Ragia, S. le Cessie, F. W. Asselbergs, A. de Boer, V. G. Manolopoulos, A. H. Maitland-van der Zee and for the EU-PACT group

    Version of Record online : 17 FEB 2017, DOI: 10.1111/jth.13615

  5. Study of the efficiency of anticoagulant rodenticides to control Mus musculus domesticus introgressed with Mus spretus Vkorc1

    Pest Management Science

    Volume 73, Issue 2, February 2017, Pages: 325–331, Joffrey Goulois, Claire Hascoët, Khedidja Dorani, Stéphane Besse, Lionel Legros, Etienne Benoit and Virginie Lattard

    Version of Record online : 23 JUN 2016, DOI: 10.1002/ps.4319

  6. Vkorc1 variation in house mice during warfarin and difenacoum field trials

    Pest Management Science

    Volume 69, Issue 3, March 2013, Pages: 409–413, Stefan Endepols, Nicole Klemann, Ying Song and Michael H Kohn

    Version of Record online : 23 APR 2012, DOI: 10.1002/ps.3306

  7. You have free access to this content
    Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment

    Journal of Thrombosis and Haemostasis

    Volume 9, Issue 1, January 2011, Pages: 109–118, M. WATZKA, C. GEISEN, C. G. BEVANS, K. SITTINGER, G. SPOHN, S. ROST, E. SEIFRIED, C. R. MÜLLER and J. OLDENBURG

    Version of Record online : 7 JAN 2011, DOI: 10.1111/j.1538-7836.2010.04095.x

  8. You have full text access to this OnlineOpen article
    Adaptative evolution of the Vkorc1 gene in Mus musculus domesticus is influenced by the selective pressure of anticoagulant rodenticides

    Ecology and Evolution

    Volume 7, Issue 8, April 2017, Pages: 2767–2776, Joffrey Goulois, Véronique Lambert, Lionel Legros, Etienne Benoit and Virginie Lattard

    Version of Record online : 21 MAR 2017, DOI: 10.1002/ece3.2829

  9. You have free access to this content
    Accuracy assessment of pharmacogenetic algorithms for warfarin dose prediction in Chinese patients

    American Journal of Hematology

    Volume 87, Issue 5, May 2012, Pages: 541–544, Xiaoying Lei, Yanhai Guo, Jianbin Sun, Heping Zhou, Yonglan Liu, Ping Liang and Zhen Yan

    Version of Record online : 28 MAR 2012, DOI: 10.1002/ajh.23151

  10. You have free access to this content
    Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon

    British Journal of Clinical Pharmacology

    Volume 77, Issue 4, April 2014, Pages: 626–641, Talitha I. Verhoef, William K. Redekop, Ann K. Daly, Rianne M. F. van Schie, Anthonius de Boer and Anke-Hilse Maitland-van der Zee

    Version of Record online : 20 MAR 2014, DOI: 10.1111/bcp.12220

  11. You have free access to this content
    Impact of genetic factors (VKORC1, CYP2C9, CYP4F2 and EPHX1) on the anticoagulation response to fluindione

    British Journal of Clinical Pharmacology

    Volume 73, Issue 3, March 2012, Pages: 428–436, Karine Lacut, Estelle Ayme-Dietrich, Lenaick Gourhant, Elise Poulhazan, Marion Andro, Laurent Becquemont, Dominique Mottier, Gregoire Le Gal and Celine Verstuyft

    Version of Record online : 13 FEB 2012, DOI: 10.1111/j.1365-2125.2011.04095.x

  12. You have free access to this content
    Long-term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol users

    Journal of Thrombosis and Haemostasis

    Volume 10, Issue 4, April 2012, Pages: 606–614, T. I. VERHOEF, W. K. REDEKOP, M. M. BUIKEMA, T. SCHALEKAMP, F. J. M. VAN DER MEER, S LE CESSIE, J. A. M. WESSELS, R. M. F. VAN SCHIE, A. DE BOER, M. TEICHERT, L. E. VISSER, A. H. MAITLAND-VAN DER ZEE and ON BEHALF OF THE EU-PACT GROUP

    Version of Record online : 30 MAR 2012, DOI: 10.1111/j.1538-7836.2012.04633.x

  13. Genotypes Associated With Reduced Activity of VKORC1 and CYP2C9 and Their Modification of Acenocoumarol Anticoagulation During the Initial Treatment Period

    Clinical Pharmacology & Therapeutics

    Volume 85, Issue 4, April 2009, Pages: 379–386, M Teichert, RHN van Schaik, A Hofman, AG Uitterlinden, PAGM de Smet, BHCh Stricker and LE Visser

    Version of Record online : 18 FEB 2009, DOI: 10.1038/clpt.2008.294

  14. Pharmacogenetics of Warfarin: Development of a Dosing Algorithm for Brazilian Patients

    Clinical Pharmacology & Therapeutics

    Volume 84, Issue 6, December 2008, Pages: 722–728, JA Perini, CJ Struchiner, E Silva-Assunção, ISC Santana, F Rangel, EB Ojopi, E Dias-Neto and G Suarez-Kurtz

    Version of Record online : 27 AUG 2008, DOI: 10.1038/clpt.2008.166

    Corrected by:

    Corrigendum: CORRIGENDUM: Pharmacogenetics of Warfarin: Development of a Dosing Algorithm for Brazilian Patients

    Vol. 85, Issue 4, 448, Version of Record online: 7 MAY 2008

  15. Age-stratified outcome of a genotype-guided dosing algorithm for acenocoumarol and phenprocoumon

    Journal of Thrombosis and Haemostasis

    Volume 15, Issue 3, March 2017, Pages: 454–464, Y. Zhang, A. de Boer, T. I. Verhoef, F. J. M. van der Meer, S. Le Cessie, V. G. Manolopoulos, A. H. Maitland-van der Zee and for the EU-PACT group

    Version of Record online : 17 FEB 2017, DOI: 10.1111/jth.13601

  16. Evidence of a target resistance to antivitamin K rodenticides in the roof rat Rattus rattus: identification and characterisation of a novel Y25F mutation in the Vkorc1 gene

    Pest Management Science

    Volume 72, Issue 3, March 2016, Pages: 544–550, Joffrey Goulois, Audrey Chapuzet, Véronique Lambert, Nolan Chatron, Luba Tchertanov, Lionel Legros, Etienne Benoît and Virginie Lattard

    Version of Record online : 26 MAY 2015, DOI: 10.1002/ps.4020

  17. VKORC1 and CYP2C9 genotypes and acenocoumarol anticoagulation status: Interaction between both genotypes affects overanticoagulation

    Clinical Pharmacology & Therapeutics

    Volume 80, Issue 1, July 2006, Pages: 13–22, Tom Schalekamp, Bjorn P Brassé, Janine F M Roijers, Youssef Chahid, Johanna H H van Geest-Daalderop, Hanneke de Vries-Goldschmeding, Eduard M van Wijk, Antoine C G Egberts and Anthonius de Boer

    Version of Record online : 3 JUL 2006, DOI: 10.1016/j.clpt.2006.04.006

  18. You have free access to this content
    An evaluation of gene–gene interaction between the CYP2C9 and VKORC1 genotypes affecting the anticoagulant effect of phenprocoumon and acenocoumarol

    Journal of Thrombosis and Haemostasis

    Volume 10, Issue 5, May 2012, Pages: 767–772, R. M. F. VAN SCHIE, A. M. V. BABAJEFF, T. SCHALEKAMP, J. A. M. WESSELS, S. LE CESSIE, A. de BOER, F. J. M. VAN DER MEER, E. VAN MEEGEN, T. I. VERHOEF, F. R. ROSENDAAL, A. H. MAITLAND-VAN DER ZEE and FOR THE EU-PACT STUDY GROUP

    Version of Record online : 2 MAY 2012, DOI: 10.1111/j.1538-7836.2012.04694.x

  19. You have free access to this content
    VKORC1 mutations detected in patients resistant to vitamin K antagonists are not all associated with a resistant VKOR activity

    Journal of Thrombosis and Haemostasis

    Volume 10, Issue 12, December 2012, Pages: 2535–2543, A. HODROGE, B. MATAGRIN, C. MOREAU, I. FOUREL, A. HAMMED, E. BENOIT and V. LATTARD

    Version of Record online : 12 DEC 2012, DOI: 10.1111/jth.12019

  20. You have free access to this content
    Pharmacodynamic resistance to warfarin is associated with nucleotide substitutions in VKORC1

    Journal of Thrombosis and Haemostasis

    Volume 6, Issue 10, October 2008, Pages: 1663–1670, D. J. HARRINGTON, R. GORSKA, R. WHEELER, S. DAVIDSON, S. MURDEN, C. MORSE, M. J. SHEARER and A. D. MUMFORD

    Version of Record online : 1 AUG 2008, DOI: 10.1111/j.1538-7836.2008.03116.x